Author:
Bildstein L.,Pili B.,Marsaud V.,Wack S.,Meneau F.,Lepêtre-Mouelhi S.,Desmaële D.,Bourgaux C.,Couvreur P.,Dubernet C.
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference46 articles.
1. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer;Sandler;J. Clin. Oncol.,2000
2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1997
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J. Clin. Oncol.,2000
4. Gemcitabine and paclitaxel in metastatic breast cancer: a review;Colomer;Oncology (Williston Park),2004
5. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group;Schilder;Gynecol. Oncol.,2000
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献